Effects of dapagliflozin combined with short-term intensive insulin therapy on β-cell function in patients with newly diagnosed type 2 diabetes mellitus—a randomized controlled study.
| Publicado en: | International Journal of Diabetes in Developing Countries Vol. 43; no. 3; pp. 384 - 392 |
|---|---|
| Autores principales: | , , |
| Formato: | equations & formulas research tables/charts randomized controlled trial Journal Article |
| Publicado: |
Springer Nature
Jun2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=163850280&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 163850280 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 09733930 259E jtl: International Journal of Diabetes in Developing Countries issn: 09733930 maglogo: N pubinfo: dt: Jun2023 vid: 43 iid: 3 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 163850280 157434703 163850280 163850280 10.1007/s13410-022-01089-w 163850280 ppf: 384 ppct: 8 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Effects of dapagliflozin combined with short-term intensive insulin therapy on β-cell function in patients with newly diagnosed type 2 diabetes mellitus—a randomized controlled study. aug: au: Lin, Min Wang, Haohua Qian, Yanli affil: Department of Endocrinology, Dongguan Tungwah Hospital, No.1, Dongcheng East Road, Dongcheng District, 523000, Dongguan, Guangdong Province, China sug: subj: Diabetes Mellitus, Type 2 Drug Therapy Dapagliflozin Therapeutic Use Insulin Resistance Evaluation Pancreatic beta Cells Physiopathology Drug Combinations Diabetic Patients Psychosocial Factors Treatment Outcomes Human Male Female Adult Middle Age Funding Source Insulin Therapeutic Use Randomized Controlled Trials Random Assignment Dapagliflozin Administration and Dosage C-Peptide Diagnostic Use Glycemic Control Glycated Hemoglobin Glucose Metabolism Disorders Hypoglycemic Agents Therapeutic Use Clinical Assessment Tools Descriptive Statistics Comparative Studies Adult: 19-44 years Middle Aged: 45-64 years Male Female pubtype: Academic Journal doctype: equations & formulas research tables/charts randomized controlled trial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|